End-stage liver disease related to chronic hepatitis C virus (HCV) infection is the leading indication for liver transplantation (LT) in the United States. Recurrence is almost universal, and HCV infection significantly impairs patient and allograft survival following LT. 1 The spectrum of histologi
β¦ LIBER β¦
Mission poorly accomplished: The protective role of natural killer cells in recurrent hepatitis C after liver transplantation
β Scribed by Nizar N. Zein
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 61 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21369
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Natural killer cells play divergent role
β
Lucy Golden-Mason
π
Article
π
2009
π
John Wiley and Sons
π
English
β 61 KB
Killer cell immunoglobulin-like receptor
β
Alejandro Espadas de Arias; Simone Elizabeth Haworth; Luca Saverio Belli; Patriz
π
Article
π
2009
π
John Wiley and Sons
π
English
β 156 KB
In 20% to 30% of infected individuals, hepatitis C virus (HCV) can cause cirrhosis and hepatocellular carcinoma, for which liver transplantation is the best treatment available. HCV re-infection is universal, and hepatitis disease recurrence occurs in most cases with a 30% probability of progression